Derfor forventes det ikke at ropinirol vil udkonkurrere metabolismen af andre lægemidler som metaboliseres af CYP1A2.
Therefore, it is not expected that ropinirole will compete with the metabolism of other medicinal products which are metabolised by CYP1A2.